Controversy over data in hydroxychloroquine COVID-19 study grows

The editors of The Lancet yesterday issued a statement acknowledging the criticism of a recent study that concluded that the antimalaria drugs hydroxychloroquine and chloroquine did not benefit COVID-19 patients and were associated with higher risk of death and […]

Click here to view original web page at Controversy over data in hydroxychloroquine COVID-19 study grows